GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
GRI Bio, Inc. (GRI)
Company Research
Source: GlobeNewswire
LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstracts have been accepted for presentation at the 14th International Congress on Autoimmunity being held May 17-20, 2024 in Ljubljana, Slovenia. Details of the presentations are as follows: Oral Presentation Title: Tissue Residency and Innate-Like Features Play Important Roles in CD8 Treg-Mediated Immune Regulation Presenter: Vipin Kumar Chaturvedi, PhD, Chief Scientific Officer of GRI BioSession: 0590 – Oral Discussions 07: Update in Pathogenesis of Autoimmune DiseasesDate and Time: Saturday, May 18, 2024 at 1:10 PM (GMT+2) Parallel Session Title: Type 2 NKT Cells Directed Immune Regulatory Mechanism in Lupus NephritisPresenter: Vipin Kumar Chaturvedi, PhD, Chief Scientific
Show less
Read more
Impact Snapshot
Event Time:
GRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRI alerts
High impacting GRI Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRI
News
- GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseGlobeNewswire
- GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
- GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar [Yahoo! Finance]Yahoo! Finance
- GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarGlobeNewswire
GRI
Sec Filings
- 5/17/24 - Form EFFECT
- 5/14/24 - Form 424B3
- 5/14/24 - Form 424B3
- GRI's page on the SEC website